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Objective: To determine the frequency with which Clostridium difficile was detected in stool specimens from 
outpatients and patients hospitalized for less than 4 days to  assess the usefulness of routine laboratory screening for 
detecting this enteric pathogen. 
Methods: Seven hundred and forty-one specimens from 398 patients were cultured over a 6-month period for 
Salmonella, Shigella, Yersinia, Escherichia coli 01 57:H7, Campylobacter and Clostridium difficile. Clostridium difficile 
culture-positive samples were further tested for cytotoxin production. 
Results: Campylobacter, Salmonella, Shigella and E. coli 0157:H7 were isolated in  50 (6.7%) specimens from 35 (8.8%) 
patients. Clostridium difficile was cultured from 88 (1 1.9%) specimens from 35 (8.8%) patients and its cytotoxin detected 
in 35 (4.7%) specimens of 12 (3%) patients. Clostridium difficile was the second most frequent enteric pathogen after 
Campylobacter. Of 178 (24%) specimens submitted with a specific request for Clostridium difficile testing, 13 (7.3%) were 
cytotoxin positive (three patients); of 563 specimens for which Clostridium difficile was not requested, 22 (3.9%) were 
cytotoxin positive (nine patients). 
Conclusions: Nine of 12 patients with cytotoxin-positive specimens would have gone undiagnosed in the laboratory 
had all stool samples submitted not been tested. These results suggest that Clostridium difficile disease is under- 
recognized and that testing all stool samples for Clostridium difficile may be warranted in  our community of patients. 
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Clostvidium dlfficile is the major cause of nosocomial 
bacterial diarrhea [ 1-31. While the role of this organism 
in diarrheal disease in hospitalized patients is well 
documented, the magnitude of its importance in 
community-acquired diarrhea is underestimated [4-5]. 
In a recent study from Australia on community- 
acquired Clostridium dficile disease, Riley et a1 [5] 
found that Clostridium d@cile was the second most 
common enteric pathogen detected after Campylobacter 
species in stool specimens from outpatients submitted 
by general practitioners. 
Corresponding author and reprint requests: 
Anne-Marie Bourgault, Departement de microbiologie 
medicale et maladies infectieuses, CHUM (pavillon Saint- 
Luc), 1058 Saint-Denis, Montreal, Quebec, Canada H2X 3J4 
Tel:+l 514 281 2100 
E-mail: ambourgauIt@sympatico.ca 
Accepted 20 August 1998 
Fax: +1 514 281 2443 
Current approaches for culturing stool specimens 
include: (1) examining for Salmonella, Shigella, Campy- 
lobarter, Yersinia and, depending on the authors, 
Escherichia coli 0157:H7 in patients with community- 
acquired diarrhea; (2)  testing the stool specimens 
submitted from patients hospitalized for more than 3 
days only for Clostridium dlfficile; and (3) testing for 
Clostridium d@cile in all patients regardless of their 
admission status upon specific request from the clinical 
staff for patients with a previous history of treatment 
with antibiotics or chemotherapeutic agents [2,6-151. 
Implementing these approaches requires excellent 
communication between physicians and laboratories; in 
reality, clinical information is often lacking or not 
pertinent on request forms. 
In view of our recent clinical experience [16] and 
reports suggesting that Clostridium d f i c i l e  might be an 
important community-acquired pathogen [5,14,17], 
we undertook a laboratory study the objective ofwhich 
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was to determine the frequency with which Clostridiurn 
dlfficile was detected in specimens submitted from 
patients with presumed community-acquired diarrhea, 
more specifically outpatients and patients admitted with 
diarrhea (hospital admission of less than 4 days), and 
hence to evaluate the usefulness of routine laboratory 
screening for this enteric pathogen in the clinical 
laboratory. 
MATERIALS AND METHODS 
From October 1995 to March 1996, 741 consecutive 
stool samples from 398 individuals submitted from 
outpatients and patients hospitalized at HBpital Saint- 
Luc for less than 4 days were prospectively worked up 
for the detection of Salmonella spp., Skigella spp., 
Yersinia enterolitica, E. coli 0157:H7, Campylobacter spp. 
and Clostridium df ic i le  (irrespective of their consistency 
or of the use of bacterial transport medium) at the 
hospital's clinical microbiology laboratory. Stool 
specimens were collected from 159 patients evaluated 
either in the emergency room or outpatient clinics or 
our institution, from 56 patients with hospital stays of 
less than 4 days and from 183 patients seen by general 
practitioners or medical specialists in their private 
offices. 
During the study period, 246 patients submitted 
specimens to the laboratory in enteric transport 
medium (Enteric Pathogen Transport media, Quelab 
Laboratories Inc., MontrCal, Canada) and 152 in clean 
containers; 96% of the stools submitted in clean 
containers were soft or liquid. 
For routine bacterial stool cultures, specimens were 
inoculated onto 5% sheep blood agar (BBL Microbiol- 
ogy Systems, Cockeysville, MD, USA), MacConkey 
(BBL), MacConkey-sorbitol (BBL), Salmonella 
Shigella (BBL), Yersinia agar (Difco Laboratories, 
Detroit, Mich, USA), Campy blood agar plates (Difco) 
and CCFA [18] sheep blood. An aliquot of each stool 
was frozen at -70OC. Clostridium d@ile culture-positive 
stool samples were further tested for cytotoxin B 
production by a tissue-culture assay on monolayers of 
Vero cells with neutralization with Clostridium dficile- 
specific antitoxin [19]. 
To evaluate physician ordering patterns for these 
tests and their impact on the laboratory results and 
therefore on clinical diagnoses, results obtained from 
stool specimens for which Clostridium dlfficile was 
specifically requested were compared to those for 
which it was not. 
The Yates corrected chi-square test was used to 
compare the recoveries of Clostridium dlfficile in both 
stool specimens and patients. We used EPIINFO 
software for the statistical analysis [20]. 
RESULTS 
Similar results for Clostridium df ic i le  culture and 
cytotoxin positivity rates were obtained irrespective of 
the stool transport system used: 10.2% and 4.4% and 
1 1.8% and 4% for transport media and clean containers, 
respectively. 
Recovery of enteric pathogens is summarized in 
Table 1. Of the 741 specimens from 398 patients 
processed during the study period, 641 (86.5%) were 
obtained from 342 (86%) outpatients and 100 (13.5%) 
were obtained from 56 (14%) patients hospitalized for 
less than 4 days. The common community-acquired 
enteric pathogens, Campylobacter, Salmonella, Shigella 
and E. coli 0157:H7, were isolated in 50 (6.7%) 
specimens from 35 (8.8%) patients. No isolates of 
Yersinia spp. were recovered. In comparison, Clostridium 
d@cile was cultured from 88 (1 1.9%) specimens from 
35 (8.8%) patients and its toxin detected in 35 (4.7%) 
specimens of 12 (3%) patients. Using the cytotoxin 
assay as the standard, Clostridium dlfficile was the second 
most frequent enteric pathogen detected in the 
laboratory after Campylobacter spp. None of the stools 
which were positive for Clostridium dtficile contained 
another enteric pathogen. 
There was a similar yield of positive results for 
Clostridium dlfficile toxin across both outpatient (2.9%) 
and inpatient groups (3.6%) (p=0.8) (Table 2). How- 
ever, inpatients had a significantly higher rate of 
positive Clostridium dlfficile cultures (6.7% versus 21.4%, 
To assess the usefulness of routine screening for 
Clostridium dlfficile in the clinical laboratory versus 
testing only on request, the data were analyzed with 
respect to the presence or absence of a request for 
Clostridium dlfficile testing on the laboratory forms (Table 
3) .  The overall Clostridium d@cile toxin positivity rate 
was 4.7%. Of 178 (24%) stool specimens (93 patients) 
submitted with a specific request for Clostridium df ic i le  
testing, 13 (7.3%) specimens (three patients) were toxin 
p < 0.001). 
Table 1 Enteric pathogens isolated &om stools 
No. (%) positive 
Specimens (n=741) Patients (n=398) 
Campylobacter spp. 30 (4) 20 (5)  
Salmonella spp. 10 (1.3) 8 (2) 
Yersinia spp. 0 0 
Shigella spp. 7 (0.9) 5 (1.3) 
E.  coli 0157:H7 3 (0.4) 2 (0.5) 
Ciostndium dr@cile 
Culture 88 (11.9) 35 (8.8) 
Cytotoxin 35 (4.7) 12 (3) 
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positive. Twenty-two (3.9%)) (nine patients) of the 563 
specimens (305 patients) for which Clostridium dlfficile 
was not requested were also cytotoxin positive. Hence, 
22 of the 35 cytotoxin-positive stool specimens would 
have gone unnoticed had routine testing of all stool 
samples not been performed, and nine of the 12 
patients with cytotoxin-positive stools would have gone 
undiagnosed in the laboratory. There was no statistical 
difference in cytotoxin positivity rates between patients 
for whom Closfridiitm dlffieile was specifically requested 
and those for whom it was not (3/93 versus 9/305 
patients, p=0.8).  The difference for Clostridium d@cilc 
stool culture positivity rates was not statistically 
significant ( I  3/93 versus 2 2 3 0 5  patients, p<0.07). 
DISCUSSION 
Infectious diarrhea in both outpatient and inpatient 
settings can be a debilitating event, and establishing its 
cause is essential to the proper management of the 
patient. It is now widely accepted that Salmonellu, 
Sh&dla, Cuiizpyhbacter and parasites are the most 
common causes of community-acquired infectious 
diarrhea and that among hospitalized patients 
Clortvidiuin dijjeilc is the pathogen most frequently 
Table 2 Summary of Clostridiurn dficiicilc stool test results for 
outpatients and patients hospitalized for less than 4 days 
Outpatients 
Total 
Culture positive 
Cytotoxiri positive 
Hospitalized 4 days 
Total 
Culture positive 
Cytotoxin positive 
No. (“h) 
Specimens Patients 
641 (86.5) 347 (86) 
61 (9.5) 13 (6.7) 
28 (4.4) 10 (2.9) 
100 (13.5) 56 (14) 
27 (27) 12 (11.4) 
7 (7) 2 (3.6) 
encountered [18]. Routine laboratory protocols for 
working up stool specimens have therefore been 
designed along these lines [11,13,21]. It is also 
recognized that decisions on whether to implement or 
discontinue any laboratory procedure should be based 
on the diagnostic value of the test and its impact on the 
management of patients [22]. 
Riley et a1 [5] have reported that Clostvidiirrn dlfficilc 
was the second most common enteric bacterial 
pathogen detected after Cumpylobacter species. They 
studied stool samples submitted from outpatients only 
by general practitioners. Their detection rate was 2.6%, 
combining both culture and cytotoxin assay results 
performed on all specimens. None of their patients had 
a recent history of hospitalization and none was residing 
in any other type ofinstitution, such as a nursing home. 
In our study as well, Clostridium dficile was the second 
most common enteric bacterial pathogen after Campy- 
lobacter spp. in stool specimens, although we studied 
outpatients and patients hospitalized for less than 4 days. 
Our results showed 11.9% culture positivity and 4.7%) 
toxin positivity rates. Clortridiuriz dficile isolates from 
cytotoxin-negative feces were not assessed for in vitro 
cytotoxin production. Not testing isolates in situations 
where toxin had not been detected directly could lead 
to the underestimation of the number of toxigenic 
Clostridium dlfficile-positive specimens [23]. Unfor- 
tunately, we do not have enough information to 
exclude patients with nosocomial Clostridium df ic i le-  
associated diarrhea, as stools from patients with a recent 
history of hospitalization may have been included in the 
analysis. 
The difference observed in culture positivity rates 
between outpatients and patients hospitalized for <4 
days can possibly be explained by two factors: patients 
with toxin-negative Clostridiurn d@ile-associated 
diarrhea are frequently hospitalized [16], and patients 
become colonized with Clostridiirm dlfficile shortly after 
admission to the hospital [2]. 
The importance of Clostridiurn d@cilc as a cause of 
Table 3 Results of Clostridium df ic i le  tests a c c o d n g  to clinicians’ original requests 
Specimens (n=74l) Patients (n=3Y8) 
Kequested Not requested Total Requested Not requested Total 
No. (“1) No. (%) No. (“A,) NO. Vt) 
Outpatients 134 (20.9) 507 (79.1) 641 69 (20.2) 173 (79.8) 342 
Culture positive 21 (15.7) 40 (7.9) 61 9 (13) 14 (5.1) 23 
Cytotoxin positive 10 (7.5) 18 (3.6) 28 2 (2.9) 8 (2.9) 10 
Culture positive 13 (27.3) 15 (26.8) 27 4 (16.7) 8 (15) 11 
Cytotoxin positive 3 (6.8) 4 (7.1) 7 1 (4.2) 1 (3.1) 2 
Hospitalized < 4 days 44 (44) 56 (56) 100 24 (42.9) 32 (57.1) 56 
2 2 2  C l i n i c a l  Microbio logy a n d  Infection, Volume 5 Number  4 ,  Apri l  1999 
diarrhea in ambulatory care medicine not only appears 
to be underestimated but is also under-recognized by 
our medical community. In outpatients, 28 specimens 
tested positive for Clostridium d&le cytotoxin but only 
10 of these would have been diagnosed had routine 
Clostridium d@cile stool testing not been carried out. Of 
recently admitted patients, four in seven would have 
been missed. Expressed in terms of patients, nine of 12 
positive patients would have gone undiagnosed. 
Our study has a number of limitations which may 
have led us to over- or underestimate the importance 
of Clostridium dficile. First, it is a strictly laboratory- 
based study and includes no clinical or epidemiologic 
correlates. The result of this is that we could not 
measure the impact of a missed laboratory diagnosis of 
Clostridium d@cile and that we could not exclude or 
distinguish community-acquired and nosocomially 
acquired but community-diagnosed Clostridium dficile- 
associated diarrhea. The frequency of truly com- 
munity-acquired Clostridium dficile disease may be 
overestimated. Second, we may have underestimated 
the prevalence of Clostridium diff^lcile, as 62% of speci- 
mens were submitted in enteric pathogen transport 
media, a process known to decrease the detection rate 
of both Clostriditrm di@ile and its toxin [3].  However, 
in this study, positivity rates for both cultures and 
cytotoxin assays were similar for specimens submitted 
with or without transport media. Finally, our labora- 
tory procedure, although somewhat unconventional by 
North American standards, with only culture-positive 
stools being tested for cytotoxin production, has 
previously been shown to give accurate results and be 
cost-effective [19]. 
In our community of patients and laboratory, we 
have found a significant number of Clostridium d@cile 
toxin-positive stools compared to those of other enteric 
pathogens routinely looked for in stool specimens, such 
as Salmonella spp. and Shigella spp. Relying solely on 
specific requests for Clostridium dficile testing, we 
would have missed the diagnosis in three-quarters of 
patients, an unacceptably high figure. Given the 
relatively high diagnostic yield from specimens that 
were not specifically submitted for Clostridium dtjicile 
testing, one could argue that investigations for Clos- 
tridium difiile should be performed routinely on stool 
samples submitted from outpatients and patients 
hospitalized for less than 4 days. More importantly, 
educational programs should be directed at all 
physicians on the role of Clostridium dtjicile as a major 
enteric pathogen in patients who have undergone 
treatment with antimicrobial or chemotherapeutic 
agents in the community, encouraging specific testing. 
At this point, from a laboratory perspective, routine 
screening of stool specimens seems to be warranted in 
our population. It may prove to be as cost-effective as 
testing for other enteric pathogens. We recommend 
that laboratories consider testing stools from the 
ambulatory setting as we have, to verify whether, in 
their setting, the same phenomenon is observed. 
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